Cortexyme shares owned by Citigroup
Historical chart of Citigroup investment in Cortexyme
Tip: Access up to 7 years of quarterly data
All positions including Cortexyme held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cortexyme by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $5.5k | 5.2k | 1.06 |
| 2023-12-31 | $5.4k | 5.2k | 1.05 |
| 2023-09-30 | $5.8k | 5.2k | 1.12 |
| 2023-03-31 | $8.1k | 5.2k | 1.56 |
| 2022-12-31 | $3.3k | 5.2k | 0.64 |
| 2022-09-30 | $7.0k | 5.6k | 1.26 |
| 2021-12-31 | $207k | 16k | 12.59 |
| 2021-03-31 | $2.4M | 67k | 36.03 |
| 2020-12-31 | $118k | 4.2k | 27.83 |
| 2020-09-30 | $45k | 909 | 49.51 |
| 2020-06-30 | $654k | 14k | 46.27 |
| 2020-03-31 | $158k | 3.5k | 45.53 |
| 2019-12-31 | $130k | 2.3k | 56.20 |
| 2019-09-30 | $4.1k | 143 | 28.99 |
| 2019-06-30 | $34k | 805 | 42.39 |